The potential role of Portulaca oleracea as a neuroprotective agent in rotenone-induced neurotoxicity and apoptosis in the brain of rats

Pesticide Biochemistry and Physiology

Volumn 105, Issue 3, 2013, Pages 203-212

  Abdel Moneim, Ahmed E ^a   Dkhil, Mohamed A ^a,b   Al Quraishy, Saleh ^b  

^a Helwan University   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Apoptosis; Oxidative stress; Portulaca oleraceae; Rats; Rotenone

Indexed keywords

PORTULACA; PORTULACA OLERACEA; PORTULACACEAE; RATTUS;

EID: 84875807832     PISSN: 00483575     EISSN: 10959939     Source Type: Journal    
DOI: 10.1016/j.pestbp.2013.02.004     Document Type: Article

References (51)

1. Mohamed A.I., Hussein A.S. Chemical composition of purslane (Portulaca oleracea). Plant Foods Hum. Nutr. 1994, 45:1-9.
2. Sudhakar D., Krishna Kishore R., Parthasarathy P.R. Portulaca oleracea L. extract ameliorates the cisplatin-induced toxicity in chick embryonic liver. Indian J. Biochem. Biophys. 2010, 47:185-189.
3. Oliveira I., Valentão P., Lopes R., Andrade P.B., Bento A., Pereira J.A. Phytochemical characterization and radical scavenging activity of Portulaca oleraceae L. leaves and stems. Microchem. J. 2009, 92:129-134.
4. Simopoulos A.P. Omega-3 fatty acids and antioxidants in edible wild plants. Biol. Res. 2004, 37:263-277.
5. Parry O., Marks J.A., Okwuasaba F.K. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J. Ethnopharmacol. 1993, 40:187-194.
6. Chan K., Islam M.W., Kamil M., Radhakrishnan R., Zakaria M.N., Habibullah M., Attas A. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J. Ethnopharmacol. 2000, 73:445-451.
7. Oh K.B., Chang I.M., Hwang K.J., Mar W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother. Res. 2000, 14:329-332.
8. Verma O.P., Kumar S., Chatterjee S.N. Antifertility effects of common edible Portulaca oleracea on the reproductive organs of male albino mice. Indian J. Med. Res. 1982, 75:301-310.
9. Gong F., Li F., Zhang L., Li J., Zhang Z., Wang G. Hypoglycemic effects of crude polysaccharide from purslane. Int. J. Mol. Sci. 2009, 10:880-888.
10. Rashed A.N., Afifi F.U., Disi A.M. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmacol. 2003, 88:131-136.
11. Kim S., Kim J., Oh M., Jung M. Antioxidant activities of selected oriental herb extracts. J. Am. Oil Chem. Soc. 1994, 71:633-640.
12. Sanchez-Reus M.I., Gomez del Rio M.A., Iglesias I., Elorza M., Slowing K., Benedi J. Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats. Neuropharmacology 2007, 52:606-616.
13. Molina-Jimenez M.F., Sanchez-Reus M.I., Andres D., Cascales M., Benedi J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res. 2004, 1009:9-16.
14. Agil A., Duran R., Barrero F., Morales B., Arauzo M., Alba F., Miranda M.T., Prieto I., Ramirez M., Vives F. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa. J. Neurol. Sci. 2006, 240:31-36.
15. Martinez-Ballesteros C., Pita-Calandre E., Sanchez-Gonzalez Y., Rodriguez-Lopez C.M., Agil A. Lipid peroxidation in adult epileptic patients treated with valproic acid. Rev. Neurol. 2004, 38:101-106.
16. Bashkatova V., Alam M., Vanin A., Schmidt W.J. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Exp. Neurol. 2004, 186:235-241.
17. Antkiewicz-Michaluk L., Karolewicz B., Romanska I., Michaluk J., Bojarski A.J., Vetulani J. 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. Eur. J. Pharmacol. 2003, 466:263-269.
18. Al-Quraishy S., Dkhil M.A., Abdel Moneim A.E. Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson's disease. Pest. Biochem. Physiol. 2012, 103:108-114.
19. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol. Cell Biochem. 2007, 295:45-52.
20. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6910-6924.
21. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. 1997, 94:7531-7536.
22. Castagne V., Lefevre K., Clarke P.G. Dual role of the NF-kappaB transcription factor in the death of immature neurons. Neuroscience 2001, 108:517-526.
23. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
24. Dkhil M.A., Abdel Moneim A.E., Al-Quraishy S., Saleh R.A. Antioxidant effect of purslane (Portulaca oleracea) and its mechanism of action. J. Med. Plants Res. 2011, 5:1589-1593.
25. Glowinski J., Axelrod J., Iversen L.L. Regional studies of catecholamines in the rat brain IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J. Pharmacol. Exp. Ther. 1966, 153:30-41.
26. Vrablic A.S., Albright C.D., Craciunescu C.N., Salganik R.I., Zeisel S.H. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J. 2001, 15:1739-1744.
27. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
28. Berkels R., Purol-Schnabel S., Roesen R. Measurement of nitric oxide by reconversion of nitrate/nitrite to NO. Methods Mol. Biol. 2004, 279:1-8.
29. Bergmeyer H.U. Methods of Enzymatic Analysis 1965, Verlag Chemie, Academic Press, Weinheim/Bergstr, New York.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
31. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
32. Pedrycz A., Czerny K. Immunohistochemical study of proteins linked to apoptosis in rat fetal kidney cells following prepregnancy adriamycin administration in the mother. Acta Histochem. 2008, 110:519-523.
33. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett J.P., Davis R.E., Parker W.D. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 1996, 40:663-671.
34. Gutman M., Singer T.P., Beinert H., Casida J.E. Reaction sites of rotenone, piericidin A, and amytal in relation to the nonheme iron components of NADH dehydrogenase. Proc. Natl. Acad. Sci. 1970, 65:763-770.
35. Lamensdorf I., Eisenhofer G., Harvey-White J., Hayakawa Y., Kirk K., Kopin I.J. Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. J. Neurosci. Res. 2000, 60:552-558.
36. Wu B., Ootani A., Iwakiri R., Fujise T., Tsunada S., Toda S., Fujimoto K. Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G580-G587.
37. Means A.R. Regulatory cascades involving calmodulin-dependent protein kinases. Mol. Endocrinol. 2000, 14:4-13.
38. Adibhatla R.M., Hatcher J.F. Role of lipids in brain injury and diseases. Future Lipidol. 2007, 2:403-422.
39. Halim A.B., el-Ahmady O., Hassab-Allah S., Abdel-Galil F., Hafez Y., Darwish A. Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage. Ann. Clin. Biochem. 1997, 34(Pt 6):656-663.
40. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
41. Klivenyi P., Andreassen O.A., Ferrante R.J., Lancelot E., Reif D., Beal M.F. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. NeuroReport 2000, 11:1265-1268.
42. Gonzalez-Hernandez T., Abdala P., Rodriguez M. NOS expression in nigral cells after excitotoxic and non-excitotoxic lesion of the pedunculopontine tegmental nucleus. Eur. J. Neurosci. 1997, 9:2658-2667.
43. He Y., Imam S.Z., Dong Z., Jankovic J., Ali S.F., Appel S.H., Le W. Role of nitric oxide in rotenone-induced nigro-striatal injury. J. Neurochem. 2003, 86:1338-1345.
44. Ouellet M., Emond V., Chen C.T., Julien C., Bourasset F., Oddo S., LaFerla F., Bazinet R.P., Calon F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem. Int. 2009, 55:476-482.
45. Wahle K.W., Rotondo D., Heys S.D. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc. Nutr. Soc. 2003, 62:349-360.
46. Avila-Gomez I.C., Velez-Pardo C., Jimenez-Del-Rio M. Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in human lymphocyte cells. Basic Clin. Pharmacol. Toxicol. 2010, 106:53-61.
47. Mukherjee P.K., Marcheselli V.L., Serhan C.N., Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. 2004, 101:8491-8496.
48. Sinha R.A., Khare P., Rai A., Maurya S.K., Pathak A., Mohan V., Nagar G.K., Mudiam M.K., Godbole M.M., Bandyopadhyay S. Anti-apoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model. Int. J. Dev. Neurosci. 2009, 27:377-383.
49. Meng H., Li C., Feng L., Cheng B., Wu F., Wang X., Li Z., Liu S. Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12. Int. J. Dev. Neurosci. 2007, 25:509-514.
50. Andersen J.K. Does neuronal loss in Parkinson's disease involve programmed cell death?. BioEssays 2001, 23:640-646.
51. Mukherjee P.K., Chawla A., Loayza M.S., Bazan N.G. Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77:233-238.